HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sven Mahner Selected Research

progesterone receptor B

1/2019Correlation of NRF2 and progesterone receptor and its effects on ovarian cancer biology.
2/2018Prostaglandin E2 receptor EP1 in healthy and diseased human endometrium.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sven Mahner Research Topics

Disease

118Neoplasms (Cancer)
12/2022 - 10/2006
89Ovarian Neoplasms (Ovarian Cancer)
02/2022 - 07/2009
44Breast Neoplasms (Breast Cancer)
03/2022 - 10/2006
30Ovarian Epithelial Carcinoma
01/2022 - 07/2009
20Vulvar Neoplasms (Vulvar Cancer)
01/2022 - 05/2010
18Uterine Cervical Neoplasms (Cancer of the Cervix)
02/2022 - 01/2011
17Neoplasm Metastasis (Metastasis)
01/2022 - 07/2009
16Carcinoma (Carcinomatosis)
01/2022 - 04/2012
12Habitual Abortion (Recurrent Miscarriage)
01/2022 - 01/2018
10Carcinogenesis
03/2021 - 10/2013
9Spontaneous Abortion (Miscarriage)
01/2022 - 01/2018
9Disease Progression
07/2021 - 01/2015
8Pre-Eclampsia (Preeclampsia)
01/2022 - 07/2017
8Ascites
01/2021 - 09/2009
7Endometrial Neoplasms (Endometrial Cancer)
12/2022 - 03/2016
6Gestational Diabetes (Gestational Diabetes Mellitus)
01/2022 - 07/2017
6Circulating Neoplastic Cells
01/2021 - 01/2017
6Residual Neoplasm
01/2020 - 02/2009
5Fetal Growth Retardation (Intrauterine Growth Retardation)
01/2019 - 12/2015
5Neutropenia
01/2018 - 01/2015
4Inflammation (Inflammations)
01/2022 - 03/2020
4Lymphatic Metastasis
01/2021 - 05/2010
4Alopecia (Baldness)
04/2020 - 01/2015
4Peritoneal Neoplasms
11/2018 - 04/2013
3Endometriosis
10/2021 - 07/2017
3Pain (Aches)
08/2021 - 05/2019
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2021 - 03/2015
3Rupture
05/2019 - 07/2013
3Thrombocytopenia (Thrombopenia)
01/2018 - 12/2016
2Pulmonary Embolism
03/2022 - 01/2018
2Squamous Cell Neoplasms (Squamous Cell Cancer)
01/2022 - 10/2021

Drug/Important Bio-Agent (IBA)

40PlatinumIBA
01/2022 - 01/2010
35Proteins (Proteins, Gene)FDA Link
01/2022 - 07/2009
20Biomarkers (Surrogate Marker)IBA
03/2022 - 01/2013
10Estrogen ReceptorsIBA
03/2022 - 09/2012
10Hormones (Hormone)IBA
08/2021 - 01/2017
9ParaffinIBA
01/2022 - 02/2013
9Messenger RNA (mRNA)IBA
11/2021 - 09/2015
8Carboplatin (JM8)FDA LinkGeneric
01/2022 - 09/2009
8Dinoprostone (PGE2)FDA Link
08/2021 - 01/2018
7Galectins (Galectin)IBA
10/2022 - 12/2015
7EnzymesIBA
11/2021 - 01/2011
7GemcitabineFDA Link
10/2020 - 04/2013
6histone H3 trimethyl Lys4IBA
01/2022 - 03/2020
6CytokinesIBA
11/2021 - 10/2020
6Estrogens (Estrogen)FDA Link
01/2021 - 09/2012
6Paclitaxel (Taxol)FDA LinkGeneric
01/2020 - 01/2015
5AntibodiesIBA
10/2021 - 05/2010
5Biological ProductsIBA
07/2021 - 02/2013
5RNA (Ribonucleic Acid)IBA
07/2021 - 11/2010
5DNA (Deoxyribonucleic Acid)IBA
01/2021 - 01/2016
5ProstaglandinsIBA
12/2020 - 07/2017
4CA-19-9 Antigen (CA 19-9 Antigen)IBA
12/2022 - 01/2017
4Lysine (L-Lysine)FDA Link
11/2021 - 03/2020
4Histones (Histone)IBA
11/2021 - 12/2017
4GTP-Binding Proteins (G-Protein)IBA
11/2021 - 01/2018
4CateninsIBA
06/2021 - 05/2017
4Prostaglandin Receptors (Prostaglandin Receptor)IBA
03/2021 - 07/2017
4Thyroid Hormone Receptors (Thyroid Hormone Receptor)IBA
01/2021 - 01/2020
4Protein Isoforms (Isoforms)IBA
01/2021 - 06/2020
4LigandsIBA
01/2021 - 01/2019
4Calcitriol Receptors (Calcitriol Receptor)IBA
10/2020 - 11/2017
4Bevacizumab (Avastin)FDA Link
01/2020 - 04/2013
4Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
01/2020 - 11/2017
4niraparibIBA
12/2019 - 12/2016
4Docetaxel (Taxotere)FDA Link
10/2018 - 09/2009
4Carbonic Anhydrase IXIBA
01/2011 - 05/2010
3Sialyl Lewis X AntigenIBA
12/2022 - 01/2017
3Progesterone Receptors (Progesterone Receptor)IBA
03/2022 - 01/2019
3Cadherins (E-Cadherin)IBA
01/2022 - 09/2015
3TeaIBA
01/2022 - 01/2019
3Co-Repressor ProteinsIBA
11/2021 - 01/2019
3Small Interfering RNA (siRNA)IBA
11/2021 - 01/2020
3Thyroid HormonesIBA
08/2021 - 02/2018
3Pharmaceutical PreparationsIBA
07/2021 - 01/2017
3AntigensIBA
04/2021 - 10/2018
3Bromodeoxyuridine (BrdU)IBA
03/2021 - 03/2020
3Mucin-1 (CA 15-3 Antigen)IBA
02/2021 - 01/2019
3CarbohydratesIBA
01/2021 - 06/2017
3Indicators and Reagents (Reagents)IBA
01/2021 - 07/2019
3AnthracyclinesIBA
10/2020 - 11/2016
3Vitamin DFDA LinkGeneric
10/2020 - 11/2017
3Plasminogen Activator Inhibitor 1IBA
09/2020 - 11/2010
3Formaldehyde (Formol)FDA Link
07/2020 - 09/2017
3liposomal doxorubicin (Doxil)FDA Link
01/2020 - 02/2015
3Galectin 1 (LGALS1)IBA
10/2019 - 04/2016
3Carrier Proteins (Binding Protein)IBA
01/2018 - 01/2013
3Estrogen Receptor alphaIBA
01/2018 - 10/2006
3Topotecan (Hycamtin)FDA LinkGeneric
01/2018 - 01/2011
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2017 - 04/2010
3taxaneIBA
03/2016 - 01/2010

Therapy/Procedure

64Therapeutics
03/2022 - 02/2009
44Drug Therapy (Chemotherapy)
03/2022 - 02/2009
9Lymph Node Excision (Lymph Node Dissection)
01/2022 - 05/2013
9Cytoreduction Surgical Procedures
10/2019 - 07/2009
8Radiotherapy
01/2021 - 04/2012
6Adjuvant Radiotherapy
01/2022 - 12/2011
6Adjuvant Chemotherapy
08/2021 - 05/2016
3Immunotherapy
07/2021 - 12/2019
3Neoadjuvant Therapy
10/2019 - 09/2009